Correlation Between Egetis Therapeutics and Vicore Pharma
Can any of the company-specific risk be diversified away by investing in both Egetis Therapeutics and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Egetis Therapeutics and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Egetis Therapeutics AB and Vicore Pharma Holding, you can compare the effects of market volatilities on Egetis Therapeutics and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Egetis Therapeutics with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Egetis Therapeutics and Vicore Pharma.
Diversification Opportunities for Egetis Therapeutics and Vicore Pharma
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Egetis and Vicore is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Egetis Therapeutics AB and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and Egetis Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Egetis Therapeutics AB are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of Egetis Therapeutics i.e., Egetis Therapeutics and Vicore Pharma go up and down completely randomly.
Pair Corralation between Egetis Therapeutics and Vicore Pharma
Assuming the 90 days trading horizon Egetis Therapeutics AB is expected to generate 1.31 times more return on investment than Vicore Pharma. However, Egetis Therapeutics is 1.31 times more volatile than Vicore Pharma Holding. It trades about 0.03 of its potential returns per unit of risk. Vicore Pharma Holding is currently generating about -0.03 per unit of risk. If you would invest 412.00 in Egetis Therapeutics AB on August 25, 2024 and sell it today you would earn a total of 122.00 from holding Egetis Therapeutics AB or generate 29.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Egetis Therapeutics AB vs. Vicore Pharma Holding
Performance |
| Timeline |
| Egetis Therapeutics |
| Vicore Pharma Holding |
Egetis Therapeutics and Vicore Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Egetis Therapeutics and Vicore Pharma
The main advantage of trading using opposite Egetis Therapeutics and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Egetis Therapeutics position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.| Egetis Therapeutics vs. Bavarian Nordic | Egetis Therapeutics vs. BioPorto | Egetis Therapeutics vs. Zaptec AS | Egetis Therapeutics vs. cBrain AS |
| Vicore Pharma vs. Bavarian Nordic | Vicore Pharma vs. BioPorto | Vicore Pharma vs. Zaptec AS | Vicore Pharma vs. cBrain AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |